Literature DB >> 8952597

Models of experimental hypertension in mice.

C Johns1, I Gavras, D E Handy, A Salomao, H Gavras.   

Abstract

Experimental models of hypertension in various animals are useful in the research of vasoactive mechanisms. Recombinant DNA technology has produced genetically engineered animals, mostly mice, useful in hypertension research. However, the development of hypertensive models in mice is fraught with technical difficulties. We describe here the successful development in mice of two common types of experimental hypertension: the renovascular two-kidney, one clip and mineralocorticoid deoxycorticosterone-salt models. By adapting technology previously used in rats, we succeeded in developing hypertension (defined as systolic pressures higher than 140 mm Hg) in more than 50% of mice so treated. We also adapted the methodology for indirect tail-cuff blood pressure measurements as well as for direct intra-arterial monitoring of blood pressure in conscious, freely moving mice. Application of these techniques in transgenic or gene knockout mice with altered vasoactive hormones or receptors should allow elucidation of the role of the target gene products in various types of hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8952597     DOI: 10.1161/01.hyp.28.6.1064

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  40 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

2.  Renovascular hypertension using a modified two-kidney, one-clip approach in mice is not dependent on the α1 or α2 Na-K-ATPase ouabain-binding site.

Authors:  John N Lorenz; Valerie M Lasko; Michelle L Nieman; Thomas Damhoff; Vikram Prasad; William H Beierwaltes; Jerry B Lingrel
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-01

3.  Mutation of the protein kinase I alpha leucine zipper domain produces hypertension and progressive left ventricular hypertrophy: a novel mouse model of age-dependent hypertensive heart disease.

Authors:  Robert M Blanton; Eiki Takimoto; Mark Aronovitz; Robrecht Thoonen; David A Kass; Richard H Karas; Michael E Mendelsohn
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-08       Impact factor: 6.053

4.  MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach.

Authors:  Victoria N Parikh; Richard C Jin; Sabrina Rabello; Natali Gulbahce; Kevin White; Andrew Hale; Katherine A Cottrill; Rahamthulla S Shaik; Aaron B Waxman; Ying-Yi Zhang; Bradley A Maron; Jochen C Hartner; Yuko Fujiwara; Stuart H Orkin; Kathleen J Haley; Albert-László Barabási; Joseph Loscalzo; Stephen Y Chan
Journal:  Circulation       Date:  2012-02-27       Impact factor: 29.690

5.  Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition.

Authors:  Sarah B Sunshine; Susan M Dallabrida; Ellen Durand; Nesreen S Ismail; Lauren Bazinet; Amy E Birsner; Regina Sohn; Sadakatsu Ikeda; William T Pu; Matthew H Kulke; Kashi Javaherian; David Zurakowski; Judah M Folkman; Maria Rupnick
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

6.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion.

Authors:  Dan Yang; Ying Zhang; Hao G Nguyen; Milka Koupenova; Anil K Chauhan; Maria Makitalo; Matthew R Jones; Cynthia St Hilaire; David C Seldin; Paul Toselli; Edward Lamperti; Barbara M Schreiber; Haralambos Gavras; Denisa D Wagner; Katya Ravid
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

7.  Plasma and liver lipid profiles in rats exposed to chronic hypobaric hypoxia: changes in metabolic pathways.

Authors:  Patricia Siques; Julio Brito; Nelson Naveas; Ruth Pulido; Juan José De la Cruz; Maribel Mamani; Fabiola León-Velarde
Journal:  High Alt Med Biol       Date:  2014-09-03       Impact factor: 1.981

8.  The effect of partial nephrectomy on blood pressure in patients with solitary kidney.

Authors:  Nikhil Gupta; Vishnu Ganesan; Tian-Min Gao; Joseph Zabell; Steven C Campbell; Georges-Pascal Haber
Journal:  World J Urol       Date:  2020-07-29       Impact factor: 4.226

9.  Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis.

Authors:  Hyung J Chun; Ziad A Ali; Yoko Kojima; Ramendra K Kundu; Ahmad Y Sheikh; Rani Agrawal; Lixin Zheng; Nicholas J Leeper; Nathan E Pearl; Andrew J Patterson; Joshua P Anderson; Philip S Tsao; Michael J Lenardo; Euan A Ashley; Thomas Quertermous
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

10.  Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP.

Authors:  Takayuki Fujino; Naoki Nakagawa; Koh-Ichi Yuhki; Akiyoshi Hara; Takehiro Yamada; Koji Takayama; Shuhko Kuriyama; Yayoi Hosoki; Osamu Takahata; Takanobu Taniguchi; Jun Fukuzawa; Naoyuki Hasebe; Kenjiro Kikuchi; Shuh Narumiya; Fumitaka Ushikubi
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.